Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons

Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of neuroscience 1994-06, Vol.14 (6), p.3881-3897
Hauptverfasser: Wong, LA, Mayer, ML, Jane, DE, Watkins, JC
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3897
container_issue 6
container_start_page 3881
container_title The Journal of neuroscience
container_volume 14
creator Wong, LA
Mayer, ML
Jane, DE
Watkins, JC
description Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl > iodo > bromo approximately chloro > nitro approximately cyano > kainate > methyl > fluoro > (R,S)-AMPA >> willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro > cyano approximately trifluoromethyl approximately nitro > chloro approximately bromo > (R,S)-AMPA > iodo > willardiine > kainate > methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate-preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.
doi_str_mv 10.1523/JNEUROSCI.14-06-03881.1994
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6576952</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15921667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3984-103c4ced992fc49f4a7e4708b00075693b2afd6446957e09be5d9e5d8908e2723</originalsourceid><addsrcrecordid>eNqFkc9u1DAQhy0EKkvhEZAsDtyy2In_xByQVkspRYWiQsXRcpJJ1pDYwU664gl4bRy6WuDEwZqDv_k0Mz-EnlGypjwvXrz7cHZzffVpe7GmLCMiI0VZ0jVVit1Dq0SoLGeE3kcrkkuSCSbZQ_Qoxq-EEEmoPEEnklOuOFuhn19s35vQWOsg4sa2LQRwkzUTYNN5Z-OEK-sa6zoc7ZSY1gf8zViXiAzfQohzxJv3HzfZGCA1h4Xs-nkyw-IIUMM4-RCxdfj19Tk2rsE7O46-NsNoeuxgDt7Fx-hBa_oITw71FN28Ofu8fZtdXp1fbDeXWV2okmWUFDWroVEqb2umWmYkMEnKalmNC1VUuWkbwZhQXAJRFfBGpVcqUkIu8-IUvbrzjnM1QFOnXYPp9RjsYMIP7Y3V__44u9Odv9WCy-RcBM8PguC_zxAnPdhYQzqiAz9HLQXPGRfkv2AKIKdCyAS-vAPr4GNMRzxOQ4le8tbHvDVlmgj9O2-95J2an_69z7H1EPCfKXa22-1tAB0H0_eJpnq_3yef0Iut-AVHrLi0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15921667</pqid></control><display><type>article</type><title>Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Wong, LA ; Mayer, ML ; Jane, DE ; Watkins, JC</creator><creatorcontrib>Wong, LA ; Mayer, ML ; Jane, DE ; Watkins, JC</creatorcontrib><description>Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl &gt; iodo &gt; bromo approximately chloro &gt; nitro approximately cyano &gt; kainate &gt; methyl &gt; fluoro &gt; (R,S)-AMPA &gt;&gt; willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro &gt; cyano approximately trifluoromethyl approximately nitro &gt; chloro approximately bromo &gt; (R,S)-AMPA &gt; iodo &gt; willardiine &gt; kainate &gt; methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate-preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.</description><identifier>ISSN: 0270-6474</identifier><identifier>EISSN: 1529-2401</identifier><identifier>DOI: 10.1523/JNEUROSCI.14-06-03881.1994</identifier><identifier>PMID: 7515954</identifier><language>eng</language><publisher>United States: Soc Neuroscience</publisher><subject>Alanine - analogs &amp; derivatives ; Alanine - pharmacology ; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - metabolism ; Animals ; Animals, Newborn ; Binding Sites ; Dose-Response Relationship, Drug ; Ganglia, Spinal - cytology ; Ganglia, Spinal - drug effects ; Ganglia, Spinal - metabolism ; Hippocampus - cytology ; Hippocampus - drug effects ; Hippocampus - metabolism ; Kainic Acid - metabolism ; Kinetics ; Neurons - metabolism ; Pyrimidinones ; Rats ; Rats, Sprague-Dawley ; Receptors, Glutamate - metabolism ; Time Factors ; Uracil</subject><ispartof>The Journal of neuroscience, 1994-06, Vol.14 (6), p.3881-3897</ispartof><rights>1994 by Society for Neuroscience 1994</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3984-103c4ced992fc49f4a7e4708b00075693b2afd6446957e09be5d9e5d8908e2723</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576952/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576952/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7515954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wong, LA</creatorcontrib><creatorcontrib>Mayer, ML</creatorcontrib><creatorcontrib>Jane, DE</creatorcontrib><creatorcontrib>Watkins, JC</creatorcontrib><title>Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons</title><title>The Journal of neuroscience</title><addtitle>J Neurosci</addtitle><description>Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl &gt; iodo &gt; bromo approximately chloro &gt; nitro approximately cyano &gt; kainate &gt; methyl &gt; fluoro &gt; (R,S)-AMPA &gt;&gt; willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro &gt; cyano approximately trifluoromethyl approximately nitro &gt; chloro approximately bromo &gt; (R,S)-AMPA &gt; iodo &gt; willardiine &gt; kainate &gt; methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate-preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.</description><subject>Alanine - analogs &amp; derivatives</subject><subject>Alanine - pharmacology</subject><subject>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - metabolism</subject><subject>Animals</subject><subject>Animals, Newborn</subject><subject>Binding Sites</subject><subject>Dose-Response Relationship, Drug</subject><subject>Ganglia, Spinal - cytology</subject><subject>Ganglia, Spinal - drug effects</subject><subject>Ganglia, Spinal - metabolism</subject><subject>Hippocampus - cytology</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - metabolism</subject><subject>Kainic Acid - metabolism</subject><subject>Kinetics</subject><subject>Neurons - metabolism</subject><subject>Pyrimidinones</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Glutamate - metabolism</subject><subject>Time Factors</subject><subject>Uracil</subject><issn>0270-6474</issn><issn>1529-2401</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc9u1DAQhy0EKkvhEZAsDtyy2In_xByQVkspRYWiQsXRcpJJ1pDYwU664gl4bRy6WuDEwZqDv_k0Mz-EnlGypjwvXrz7cHZzffVpe7GmLCMiI0VZ0jVVit1Dq0SoLGeE3kcrkkuSCSbZQ_Qoxq-EEEmoPEEnklOuOFuhn19s35vQWOsg4sa2LQRwkzUTYNN5Z-OEK-sa6zoc7ZSY1gf8zViXiAzfQohzxJv3HzfZGCA1h4Xs-nkyw-IIUMM4-RCxdfj19Tk2rsE7O46-NsNoeuxgDt7Fx-hBa_oITw71FN28Ofu8fZtdXp1fbDeXWV2okmWUFDWroVEqb2umWmYkMEnKalmNC1VUuWkbwZhQXAJRFfBGpVcqUkIu8-IUvbrzjnM1QFOnXYPp9RjsYMIP7Y3V__44u9Odv9WCy-RcBM8PguC_zxAnPdhYQzqiAz9HLQXPGRfkv2AKIKdCyAS-vAPr4GNMRzxOQ4le8tbHvDVlmgj9O2-95J2an_69z7H1EPCfKXa22-1tAB0H0_eJpnq_3yef0Iut-AVHrLi0</recordid><startdate>19940601</startdate><enddate>19940601</enddate><creator>Wong, LA</creator><creator>Mayer, ML</creator><creator>Jane, DE</creator><creator>Watkins, JC</creator><general>Soc Neuroscience</general><general>Society for Neuroscience</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19940601</creationdate><title>Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons</title><author>Wong, LA ; Mayer, ML ; Jane, DE ; Watkins, JC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3984-103c4ced992fc49f4a7e4708b00075693b2afd6446957e09be5d9e5d8908e2723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Alanine - analogs &amp; derivatives</topic><topic>Alanine - pharmacology</topic><topic>alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - metabolism</topic><topic>Animals</topic><topic>Animals, Newborn</topic><topic>Binding Sites</topic><topic>Dose-Response Relationship, Drug</topic><topic>Ganglia, Spinal - cytology</topic><topic>Ganglia, Spinal - drug effects</topic><topic>Ganglia, Spinal - metabolism</topic><topic>Hippocampus - cytology</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - metabolism</topic><topic>Kainic Acid - metabolism</topic><topic>Kinetics</topic><topic>Neurons - metabolism</topic><topic>Pyrimidinones</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Glutamate - metabolism</topic><topic>Time Factors</topic><topic>Uracil</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wong, LA</creatorcontrib><creatorcontrib>Mayer, ML</creatorcontrib><creatorcontrib>Jane, DE</creatorcontrib><creatorcontrib>Watkins, JC</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wong, LA</au><au>Mayer, ML</au><au>Jane, DE</au><au>Watkins, JC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons</atitle><jtitle>The Journal of neuroscience</jtitle><addtitle>J Neurosci</addtitle><date>1994-06-01</date><risdate>1994</risdate><volume>14</volume><issue>6</issue><spage>3881</spage><epage>3897</epage><pages>3881-3897</pages><issn>0270-6474</issn><eissn>1529-2401</eissn><abstract>Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl &gt; iodo &gt; bromo approximately chloro &gt; nitro approximately cyano &gt; kainate &gt; methyl &gt; fluoro &gt; (R,S)-AMPA &gt;&gt; willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro &gt; cyano approximately trifluoromethyl approximately nitro &gt; chloro approximately bromo &gt; (R,S)-AMPA &gt; iodo &gt; willardiine &gt; kainate &gt; methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate-preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.</abstract><cop>United States</cop><pub>Soc Neuroscience</pub><pmid>7515954</pmid><doi>10.1523/JNEUROSCI.14-06-03881.1994</doi><tpages>17</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-6474
ispartof The Journal of neuroscience, 1994-06, Vol.14 (6), p.3881-3897
issn 0270-6474
1529-2401
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6576952
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Alanine - analogs & derivatives
Alanine - pharmacology
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid - metabolism
Animals
Animals, Newborn
Binding Sites
Dose-Response Relationship, Drug
Ganglia, Spinal - cytology
Ganglia, Spinal - drug effects
Ganglia, Spinal - metabolism
Hippocampus - cytology
Hippocampus - drug effects
Hippocampus - metabolism
Kainic Acid - metabolism
Kinetics
Neurons - metabolism
Pyrimidinones
Rats
Rats, Sprague-Dawley
Receptors, Glutamate - metabolism
Time Factors
Uracil
title Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T11%3A28%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Willardiines%20differentiate%20agonist%20binding%20sites%20for%20kainate-%20versus%20AMPA-preferring%20glutamate%20receptors%20in%20DRG%20and%20hippocampal%20neurons&rft.jtitle=The%20Journal%20of%20neuroscience&rft.au=Wong,%20LA&rft.date=1994-06-01&rft.volume=14&rft.issue=6&rft.spage=3881&rft.epage=3897&rft.pages=3881-3897&rft.issn=0270-6474&rft.eissn=1529-2401&rft_id=info:doi/10.1523/JNEUROSCI.14-06-03881.1994&rft_dat=%3Cproquest_pubme%3E15921667%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15921667&rft_id=info:pmid/7515954&rfr_iscdi=true